NASDAQ: NEPH
- Last Close 1.46
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Investment Style Small Blend
- Day Range 1.45 – 1.46
- Year Range 0.93 – 2.50
- Market Cap 15.3080 Mil
- Volume / Avg 1,064.0 / 6,622.8
- Price / Sales 1.22
- Price / Book 1.76
- Forward Div Yield —
- Trailing Div Yield —
Morningstar‘s Stock Analysis NEPH
1-Star Price
INVESTOR
5-Star Price
INVESTOR
Economic Moat
INVESTOR
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile NEPH
Nephros Inc is a commercial-stage company that develops and sells high performance water solutions to the medical and commercial markets. In medical markets, it sell water filtration products and waterborne pathogen detection products. In commercial markets, the company manufacture and sell water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The operating segments of the group are Water Filtration, Pathogen Detection and Renal Products of which key revenue is derived from Water Filtration segment.
Our Quantitative Research team models direct competitors or comparable companies from a bottom-up perspective to find companies describing their business in a similar fashion.
Nephros Inc
XNAS: NEPH
| Retractable Technologies Inc
XASE: RVP
| ShockWave Medical Inc
XNAS: SWAV
| Biomerica Inc
XNAS: BMRA
| |
Price
| 1.46 | 1.21 | 196.31 | 0.84 |
Currency
| USD | USD | USD | USD |
Change
| −$0.02 (1.35%) | +$0.02 (1.68%) | −$2.79 (1.40%) | −$0.02 (2.46%) |
Market Cap
| 15.31 Mil | 36.22 Mil | 7.21 Bil | 14.11 Mil |
Industry
| Medical Instruments & Supplies | Medical Instruments & Supplies | Medical Devices | Medical Devices |
Sector
|
Healthcare
|
Healthcare
|
Healthcare
|
Healthcare
|
* Trading data in this section is delayed by at least 15 minutes.
FAQs for Nephros Inc Stock
No. NEPH does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks,
to compare the relationship between a stock’s price and how it rewards stockholders through dividends.
The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
NEPH’s market cap is 15.31 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares.
It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the
largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.
Learn more about market capitalization.
NEPH’s stock style is Small Core.
Style is an investment factor that has a meaningful impact on investment risk and returns.
Style is calculated by combining value and growth scores, which are first individually calculated.
High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.
Learn more about style.
NEPH’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare NEPH’s historical performance against its industry peers and the overall market.